Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03887741 · ClinicalTrials.gov registry record · Phase 1
Plasmapheresis Versus Plasma Infusion from Young APOE3 Homozygotes Into MCI APOE4 Homozygotes to Slow Disease Progression
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT03887741: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT03887741 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03887741, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
Determine safety of plasma infusion or exchange in APOE 44 patients.
Interventions
- BIOLOGICAL Plasmapheresis
- BIOLOGICAL Plasma infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2024-02-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03887741
The ClinicalTrials.gov registry entry for NCT03887741 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Plasmapheresis is the first listed.
NCT03887741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03887741 about?
NCT03887741 is a clinical study titled "Plasmapheresis Versus Plasma Infusion from Young APOE3 Homozygotes Into MCI APOE4 Homozygotes to Slow Disease Progression". Determine safety of plasma infusion or exchange in APOE 44 patients.
What is the current status of trial NCT03887741?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2021-09-15. Estimated completion is 2024-02-16.
What interventions are being tested in trial NCT03887741?
The interventions under investigation include: Plasmapheresis (BIOLOGICAL), Plasma infusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT03887741?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.